Stone Ridge Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,776
Closed -$645K 350
2020
Q2
$645K Sell
20,776
-8,222
-28% -$279K 0.1% 207
2020
Q1
$898K Buy
28,998
+6,957
+32% +$237K 0.1% 232
2019
Q4
$819K Sell
22,041
-17,075
-44% -$608K 0.05% 461
2019
Q3
$1.33M Buy
39,116
+8,537
+28% +$310K 0.08% 311
2019
Q2
$1.26M Buy
30,579
+24,453
+399% +$971K 0.07% 327
2019
Q1
$247K Sell
6,126
-985,735
-99% -$39.5M 0.01% 973
2018
Q4
$41.1M Buy
991,861
+641,433
+183% +$26.6M 2.51% 2
2018
Q3
$14.7M Buy
350,428
+107,183
+44% +$4.13M 0.79% 14
2018
Q2
$8.37M Hold
243,245
0.48% 30
2018
Q1
$8.19M Buy
243,245
+67,919
+39% +$2.33M 0.48% 29
2017
Q4
$6.03M Buy
+175,326
New +$5.98M 0.38% 29
2016
Q1
Sell
-6,746
Closed -$207K 85
2015
Q4
$207K Hold
6,746
0.7% 78
2015
Q3
$201K Hold
6,746
0.79% 85
2015
Q2
$215K Hold
6,746
0.5% 102
2015
Q1
$223K Buy
+6,746
New +$214K 0.56% 106

Other funds holding PFE

Stone Ridge Asset Management's PFE Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Pfizer (PFE) in Q3 2020, closing a stake of 20,776 shares — an estimated $645K sold.

Stone Ridge Asset Management first reported a position in PFE in Q1 2015 and held it in 15 quarters. The position peaked at $41.1M in Q4 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Stone Ridge Asset Management reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 20,776 Pfizer shares in Q3 2020, an estimated $645K.
  • Stone Ridge Asset Management first reported a position in Pfizer in Q1 2015 and held it in 15 quarters.
  • Stone Ridge Asset Management's Pfizer position peaked at $41.1M in Q4 2018.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.